HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC.

AbstractBACKGROUND AND AIMS:
Poor response to ionizing radiation (IR) due to resistance remains a clinical challenge. Altered metabolism represents a defining characteristic of nearly all types of cancers. However, how radioresistance is linked to metabolic reprogramming remains elusive in hepatocellular carcinoma (HCC).
APPROACH AND RESULTS:
Baseline radiation responsiveness of different HCC cells were identified and cells with acquired radio-resistance were generated. By performing proteomics, metabolomics, metabolic flux, and other functional studies, we depicted a metabolic phenotype that mediates radiation resistance in HCC, whereby increased glucose flux leads to glucose addiction in radioresistant HCC cells and a corresponding increase in glycerophospholipids biosynthesis to enhance the levels of cardiolipin. Accumulation of cardiolipin dampens the effectiveness of IR by inhibiting cytochrome c release to initiate apoptosis. Mechanistically, mammalian target of rapamycin complex 1 (mTORC1) signaling-mediated translational control of hypoxia inducible factor-1α (HIF-1α) and sterol regulatory element-binding protein-1 (SREBP1) remodels such metabolic cascade. Targeting mTORC1 or glucose to cardiolipin synthesis, in combination with IR, strongly diminishes tumor burden. Finally, activation of glucose metabolism predicts poor response to radiotherapy in cancer patients.
CONCLUSIONS:
We demonstrate a link between radiation resistance and metabolic integration and suggest that metabolically dismantling the radioresistant features of tumors may provide potential combination approaches for radiotherapy in HCC.
AuthorsYuan Fang, Yizhi Zhan, Yuwen Xie, Shisuo Du, Yuhan Chen, Zhaochong Zeng, Yaowei Zhang, Keli Chen, Yongjia Wang, Li Liang, Yi Ding, Dehua Wu
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 75 Issue 6 Pg. 1386-1401 (06 2022) ISSN: 1527-3350 [Electronic] United States
PMID34580888 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Chemical References
  • Cardiolipins
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Sterol Regulatory Element Binding Protein 1
  • Mechanistic Target of Rapamycin Complex 1
  • Glucose
Topics
  • Carcinoma, Hepatocellular (metabolism)
  • Cardiolipins (metabolism)
  • Cell Line, Tumor
  • Glucose (metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Liver Neoplasms (genetics)
  • Mechanistic Target of Rapamycin Complex 1
  • Radiation Tolerance
  • Sterol Regulatory Element Binding Protein 1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: